デジタルフェノタイピングの世界市場

デジタルフェノタイピングの世界市場は2030年までに26億米ドルに達する

2024年に16億米ドルと推定されるデジタルフェノタイピングの世界市場は、2024年から2030年にかけてCAGR 8.6%で成長し、2030年には26億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるアクティブデータストリームは、CAGR 9.9%を記録し、分析期間終了時には19億米ドルに達すると予測されます。パッシブデータストリームセグメントの成長率は、分析期間中CAGR 5.7%と推定されます。

米国市場は4億2,920万米ドルと推定、中国はCAGR13.7%で成長予測

米国のデジタルフェノタイピング市場は、2024年に4億2,920万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを13.7%として、2030年までに5億7,060万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.3%と8.3%と予測されています。欧州では、ドイツがCAGR 5.8%で成長すると予測されています。

世界のデジタルフェノタイピング市場- 主要動向と促進要因まとめ

デジタルフェノタイピングとは何か、なぜヘルスモニタリングで注目されているのか？

デジタルフェノタイピングとは、スマートフォンやウェアラブルなどのパーソナルデジタルデバイスからデータをリアルタイムで収集・分析し、個人の精神的・身体的健康に関連する行動パターンや生理的パターンを評価することを指します。動作、発話、タイピングパターン、睡眠サイクル、社会的相互作用、GPSデータなどの変数を受動的に監視することにより、デジタルフェノタイピングは個人の健康状態の動的かつ継続的なプロファイルを生成します。このデータ駆動型のアプローチにより、特にメンタルヘルス、神経学、慢性疾患管理において、異常の早期発見、個別化された介入、長期的な追跡が可能になります。

メンタルヘルスの有病率の増加は、パーソナライズされた予防的ケアへの世界の後押しと相まって、デジタルフェノタイピングをデジタルヘルスにおける画期的なソリューションとして位置づけています。デジタルフェノタイピングは、臨床医に患者の現実世界での行動に関する、より深い文脈に基づいた洞察を提供します。調査においては、デジタル行動と精神医学的または神経学的転帰との相関関係を理解するための新たな道筋を開き、人間の健康についてのより微妙な理解を可能にします。

どのテクノロジーがデジタルフェノタイピングアプリケーションの成長を後押ししていますか？

デジタルフェノタイピングは、スマートフォンのセンサー、ウェアラブル、機械学習、行動分析など、さまざまな先進技術を活用しています。携帯電話は、そのユビキタス性とセンサーの豊富なアーキテクチャにより、加速度計、通話/テキストメタデータ、アプリの使用状況、位置情報などのパッシブデータを取得し、主要なプラットフォームとして機能します。ウェアラブルは、心拍数、皮膚コンダクタンス、睡眠サイクルなどの生理学的信号を表現型データセットに追加することで、これらの機能を拡張します。

その後、機械学習アルゴリズムが適用され、行動パターンを導き出し、基準値からの逸脱を検出し、臨床的リスク事象を予測します。自然言語処理（NLP）は、感情的なトーン、認知機能の低下、ストレスの指標について音声やテキストデータを分析するためにも使用されます。セキュアなクラウドプラットフォームとエッジコンピューティングモデルは、プライバシー管理を強化したリアルタイム分析を可能にし、データの暗号化と非識別化技術は、進化するデジタルヘルス・プライバシー規制へのコンプライアンスを確保するのに役立っています。

どの使用事例がヘルスケアおよび調査エコシステム全体での採用を促進しているのか？

デジタルフェノタイピングは、うつ病、不安障害、双極性障害、統合失調症、PTSDなどの状態を監視するために使用されている精神医学と行動医学で、強力な採用が進んでいます。臨床医は、気分の変化を検出し、再発の早期警告兆候を特定し、治療の個別化を改善するために受動的データを使用しています。また、アルツハイマー病やパーキンソン病などの神経変性疾患における記憶、注意、実行機能を追跡するために、認知機能の健康管理にも利用されています。

慢性疾患管理では、デジタルフェノタイピングは糖尿病、心血管疾患、肥満などの症状におけるライフスタイル行動、治療アドヒアランス、生理学的反応のモニタリングに役立ちます。学術研究機関や製薬研究機関は、縦断的研究、実際のエビデンス作成、デジタルバイオマーカー開発においてデジタルフェノタイピングを活用しています。青少年の健康、妊産婦の健康、中毒回復、デジタル治療薬などの新たなアプリケーションは、特に遠隔地や十分なサービスを受けていない人々において、その範囲をさらに拡大しています。

デジタルフェノタイピング市場の急拡大の原動力は？

デジタルフェノタイピング市場の成長は、モバイルヘルス技術の臨床ケアへの統合の拡大、継続的でパーソナライズされた健康モニタリングへの需要の高まり、行動分析およびデジタルメンタルヘルスプラットフォームへの投資の増加など、いくつかの要因によってもたらされています。ヘルスケアプロバイダーや研究者は、特に精神医学や予防医学において、従来のエピソード型ケアモデルが残したギャップを埋めるためにデジタルフェノタイピングを利用するようになってきています。

メンタルヘルスに対する世界の意識の高まり、ウェアラブルバイオセンサーの普及、アウトカムベースのケアへのシフト、拡張可能なリモートモニタリングツールの必要性といったエンドユースの動向が、導入に拍車をかけています。デジタル治療薬と患者参加型プラットフォームの出現も、統合型表現型ツールの需要を喚起しています。デジタルヘルスエコシステムが成熟し、規制の枠組みが受動的なヘルスモニタリングをサポートするように進化するにつれて、デジタルフェノタイピングはデータ駆動型のプロアクティブヘルスケア提供の基盤となる要素になると考えられます。

セグメント

データストリーム（アクティブデータストリーム、パッシブデータストリーム）、デバイスタイプ（スマートフォンデバイス、ウェアラブル医療デバイス、その他のデバイス）、アプリケーション（気分障害アプリケーション、双極性障害アプリケーション、オピオイド過剰摂取検出アプリケーション、有害飲酒行動アプリケーション、その他のアプリケーション）

調査対象企業の例（注目の42社）

• Affective
• Aiva Health
• Biovotion
• BrainCheck
• Cambridge Cognition
• Cognito Therapeutics
• Evidation Health
• Mindstrong Health
• mPulse Mobile
• NeuroLex Laboratories
• Neurotrack Technologies
• NovuMind
• Pear Therapeutics
• Qolware
• Roche Digital Health
• Sano Intelligence
• Sentio Solutions
• SilverCloud Health
• Unmind
• Winterlight Labs

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Digital Phenotyping Market to Reach US$2.6 Billion by 2030

The global market for Digital Phenotyping estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Active Data Stream, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$1.9 Billion by the end of the analysis period. Growth in the Passive Data Stream segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$429.2 Million While China is Forecast to Grow at 13.7% CAGR

The Digital Phenotyping market in the U.S. is estimated at US$429.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$570.6 Million by the year 2030 trailing a CAGR of 13.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Digital Phenotyping Market - Key Trends & Drivers Summarized

What Is Digital Phenotyping and Why Is It Gaining Attention in Health Monitoring?

Digital phenotyping refers to the real-time collection and analysis of data from personal digital devices-such as smartphones and wearables-to assess behavioral and physiological patterns that relate to an individual's mental or physical health. By passively monitoring variables such as movement, speech, typing patterns, sleep cycles, social interactions, and GPS data, digital phenotyping generates a dynamic and continuous profile of an individual’s health state. This data-driven approach enables early detection of anomalies, personalized interventions, and longitudinal tracking, especially in mental health, neurology, and chronic disease management.

The increasing prevalence of mental health conditions, coupled with a global push toward personalized and preventive care, is positioning digital phenotyping as a breakthrough solution in digital health. It shifts the paradigm from episodic, clinic-based assessments to continuous, ecological monitoring-providing clinicians with deeper, contextual insights into patients’ real-world behavior. In research, it opens new pathways to understand correlations between digital behavior and psychiatric or neurological outcomes, enabling a more nuanced understanding of human health.

Which Technologies Are Empowering the Growth of Digital Phenotyping Applications?

Digital phenotyping leverages a range of advanced technologies including smartphone sensors, wearables, machine learning, and behavioral analytics. Mobile phones serve as the primary platform due to their ubiquity and sensor-rich architecture, capturing passive data such as accelerometry, call/text metadata, app usage, and geolocation. Wearables extend these capabilities by adding physiological signals like heart rate, skin conductance, and sleep cycles into the phenotypic dataset.

Machine learning algorithms are then applied to derive behavioral patterns, detect deviations from baseline norms, and predict clinical risk events. Natural language processing (NLP) is also used to analyze speech and text data for emotional tone, cognitive decline, or stress indicators. Secure cloud platforms and edge computing models are enabling real-time analytics with enhanced privacy controls, while data encryption and de-identification techniques help ensure compliance with evolving digital health privacy regulations.

Which Use Cases Are Driving Adoption Across Healthcare and Research Ecosystems?

Digital phenotyping is gaining strong adoption in psychiatry and behavioral health, where it is being used to monitor conditions such as depression, anxiety, bipolar disorder, schizophrenia, and PTSD. Clinicians are using passive data to detect mood changes, identify early warning signs of relapse, and improve treatment personalization. It is also being used in cognitive health to track memory, attention, and executive function in neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease.

In chronic disease management, digital phenotyping helps monitor lifestyle behaviors, treatment adherence, and physiological response in conditions like diabetes, cardiovascular disease, and obesity. Academic and pharmaceutical research organizations are leveraging digital phenotyping in longitudinal studies, real-world evidence generation, and digital biomarker development. Emerging applications in adolescent health, maternal wellness, addiction recovery, and digital therapeutics are expanding the scope further, particularly in remote and underserved populations.

What Is Driving the Rapid Expansion of the Digital Phenotyping Market?

The growth in the digital phenotyping market is driven by several factors, including the expanding integration of mobile health technologies into clinical care, growing demand for continuous and personalized health monitoring, and rising investments in behavioral analytics and digital mental health platforms. Healthcare providers and researchers are increasingly turning to digital phenotyping to fill the gaps left by traditional episodic care models, especially in psychiatry and preventive medicine.

End-use trends such as the global rise in mental health awareness, the proliferation of wearable biosensors, the shift toward outcome-based care, and the need for scalable remote monitoring tools are fueling adoption. The emergence of digital therapeutics and patient engagement platforms is also catalyzing demand for integrated phenotyping tools. As digital health ecosystems mature and regulatory frameworks evolve to support passive health monitoring, digital phenotyping is set to become a foundational element in data-driven, proactive healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Digital Phenotyping market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Data Stream (Active Data Stream, Passive Data Stream); Device Type (Smartphone Devices, Wearable Medical Devices, Other Devices); Application (Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application, Harmful Alcohol Drinking Behavior Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Affective
• Aiva Health
• Biovotion
• BrainCheck
• Cambridge Cognition
• Cognito Therapeutics
• Evidation Health
• Mindstrong Health
• mPulse Mobile
• NeuroLex Laboratories
• Neurotrack Technologies
• NovuMind
• Pear Therapeutics
• Qolware
• Roche Digital Health
• Sano Intelligence
• Sentio Solutions
• SilverCloud Health
• Unmind
• Winterlight Labs

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Digital Phenotyping - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growth in Mental Health Monitoring Solutions Propels Adoption of Digital Phenotyping Platforms
  • Increased Use of Smartphone Data for Behavioral Insights Throws Spotlight on Passive Health Tracking
  • OEM Integration With Wearables and Mobile Sensors Enhances Granularity in Real-Time Data Collection
  • Adoption in Clinical Trials Supports Objective Biomarkers for Neuropsychiatric Disorder Diagnosis
  • AI-Driven Mood and Activity Pattern Recognition Accelerates Use in Depression and Anxiety Management
  • Rising Demand for Remote Patient Monitoring Fuels Deployment in Behavioral Health Settings
  • Digital Therapeutics Development Leverages Phenotyping to Personalize Treatment Recommendations
  • University and Hospital Collaborations Strengthen Clinical Validation of Digital Phenotyping Algorithms
  • Ethical Data Use and Consent Frameworks Shape Regulatory Direction for Phenotyping Platforms
  • Focus on Predictive Analytics and Early Warning Systems Enhances Use in Suicide Prevention Programs
  • Growth in Youth Mental Health Interventions Encourages School-Based Deployment of Digital Phenotyping
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Digital Phenotyping Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Digital Phenotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Digital Phenotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Digital Phenotyping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Active Data Stream by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Active Data Stream by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Active Data Stream by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Passive Data Stream by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Passive Data Stream by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Passive Data Stream by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Mood Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Mood Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Mood Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Bipolar Disorder Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Bipolar Disorder Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Bipolar Disorder Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Opioid Overdose Detection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Opioid Overdose Detection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Opioid Overdose Detection Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Harmful Alcohol Drinking Behavior Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Harmful Alcohol Drinking Behavior Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Harmful Alcohol Drinking Behavior Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Smartphone Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Smartphone Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Smartphone Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Wearable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Wearable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Wearable Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• JAPAN
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• CHINA
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• EUROPE
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Digital Phenotyping by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Digital Phenotyping by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Digital Phenotyping by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• FRANCE
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• GERMANY
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Digital Phenotyping by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Digital Phenotyping by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Digital Phenotyping by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• INDIA
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Digital Phenotyping by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Digital Phenotyping by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Digital Phenotyping by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Digital Phenotyping by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Digital Phenotyping by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Digital Phenotyping by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030
• AFRICA
  • Digital Phenotyping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Digital Phenotyping by Data Stream - Active Data Stream and Passive Data Stream Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Digital Phenotyping by Data Stream - Percentage Breakdown of Value Sales for Active Data Stream and Passive Data Stream for the Years 2014, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Digital Phenotyping by Application - Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Digital Phenotyping by Application - Percentage Breakdown of Value Sales for Other Applications, Mood Disorders Application, Bipolar Disorder Application, Opioid Overdose Detection Application and Harmful Alcohol Drinking Behavior Application for the Years 2014, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Digital Phenotyping by Device Type - Smartphone Devices, Wearable Medical Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Digital Phenotyping by Device Type - Percentage Breakdown of Value Sales for Smartphone Devices, Wearable Medical Devices and Other Devices for the Years 2014, 2025 & 2030

IV. COMPETITION